Cash flow Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

Food Processing

End-of-day quote Taipei Exchange Other stock markets 2026-04-16			5-day change	1st Jan Change
47.50 ^TWD	+1.06%		+0.32%	+6.03%

Mar. 11	Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Jan. 07	Rakuten Medical, Inc. announces tranche update	CI

9c57f17f88728b9bc5e95e1c9ae825.nTbA7UuQB4NXhMYrA7ki5G0JKlMd3FUOEl3oGBi51yQ._16qsifzMLEh5oRtTthyrSF4X2ZcnxB3SwjacUjDtGXreJa7LeNVyTi0lw

Published financial data: ORIENT EUROPHARMA CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.77B	4.73B	4.59B	4.39B	4.6B
Total Revenues	4.77B	4.73B	4.59B	4.39B	4.6B
Cost of Goods Sold, Total	2.62B	2.7B	2.44B	2.33B	2.36B
Gross Profit	2.15B	2.03B	2.15B	2.07B	2.24B
Selling General & Admin Expenses, Total	1.92B	1.92B	1.87B	1.81B	1.98B
Provision for Bad Debts	-	-396K	1.53M	20.04M	11.72M
R&D Expenses	331M	260M	207M	242M	558M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses, Total	2.25B	2.18B	2.08B	2.07B	2.55B
Operating Income	-98.15M	-150M	70.61M	-6.72M	-311M
Interest Expense, Total	-38.04M	-69.53M	-106M	-107M	-74.06M
Interest And Investment Income	11.85M	20.96M	50.86M	48.87M	34.38M
Net Interest Expenses	-26.18M	-48.57M	-55.24M	-58.36M	-39.68M
Income (Loss) On Equity Invest.	-19.14M	-30.14M	-18.26M	-27.29M	-61.01M
Currency Exchange Gains (Loss)	11.6M	-178M	-25.59M	-112M	88.12M
Other Non Operating Income (Expenses)	41.69M	40.54M	50.08M	71.11M	57.04M
EBT, Excl. Unusual Items	-90.18M	-365M	21.6M	-133M	-266M
Gain (Loss) On Sale Of Investments	-	-	-	6.15M	-
Gain (Loss) On Sale Of Assets	182M	72.35M	234M	-4.83M	1.41M
Asset Writedown	-10M	-35.3M	-	-	-8.65M
Other Unusual Items	2.56M	45K	158K	1.8M	275K
EBT, Incl. Unusual Items	84.77M	-328M	256M	-130M	-273M
Income Tax Expense	10.47M	-32.77M	86.97M	101M	207M
Earnings From Continuing Operations	74.3M	-295M	169M	-231M	-480M
Net Income to Company	74.3M	-295M	169M	-231M	-480M
Minority Interest	45.88M	-15.44M	-25.34M	-52.74M	-87.2M
Net Income - (IS)	120M	-311M	144M	-284M	-567M
Net Income to Common Incl Extra Items	120M	-311M	144M	-284M	-567M
Net Income to Common Excl. Extra Items	120M	-311M	144M	-284M	-567M
Per Share Items
Net EPS - Basic	1.39	-3.58	1.66	-3.27	-6.54
Basic EPS - Continuing Operations	1.39	-3.58	1.66	-3.27	-6.54
Basic Weighted Average Shares Outstanding	86.75M	86.75M	86.75M	86.75M	86.75M
Net EPS - Diluted	1.38	-3.58	1.66	-3.27	-6.54
Diluted EPS - Continuing Operations	1.38	-3.58	1.66	-3.27	-6.54
Diluted Weighted Average Shares Outstanding	86.96M	86.75M	86.95M	86.75M	86.75M
Normalized Basic EPS	-0.12	-2.81	-0.14	-1.57	-2.92
Normalized Diluted EPS	-0.12	-2.81	-0.14	-1.57	-2.92
Dividend Per Share	0.85	-	1	1	4
Payout Ratio	108.28	-23.72	-	-30.55	-15.29
Supplemental Items
EBITDA	57.87M	28.61M	236M	153M	-155M
EBITA	-75.48M	-143M	74.72M	-3.53M	-307M
EBIT	-98.15M	-150M	70.61M	-6.72M	-311M
EBITDAR	77.45M	55.03M	253M	175M	-130M
Effective Tax Rate - (Ratio)	12.35	9.99	33.94	-77.86	-75.87
Total Current Taxes	44.79M	38.81M	199M	61.01M	169M
Total Deferred Taxes	-34.32M	-71.58M	-112M	40.2M	37.79M
Normalized Net Income	-10.48M	-244M	-11.85M	-136M	-253M
Interest on Long-Term Debt	4.1M	5.19M	7.73M	7.06M	3.65M
Non-Cash Pension Expense	254K	2M	876K	532K	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.21B	1.2B	1.12B	1.03B	1.18B
General and Administrative Expenses	705M	724M	745M	776M	802M
Research And Development Expense From Footnotes	331M	260M	207M	242M	558M
Net Rental Expense, Total	19.58M	26.42M	17.6M	21.42M	25.5M
Imputed Operating Lease Interest Expense	1.8M	3.18M	3.03M	4.05M	4.03M
Imputed Operating Lease Depreciation	17.78M	23.24M	14.57M	17.37M	21.46M
Stock-Based Comp., Other (Total)	136K	-	-	-	640K
Total Stock-Based Compensation	136K	-	-	-	640K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.96B	1.8B	1.74B	1.44B	1.95B
Short Term Investments	80.8M	70.8M	366M	174M	136M
Total Cash And Short Term Investments	2.04B	1.87B	2.1B	1.61B	2.09B
Accounts Receivable, Total	580M	730M	783M	847M	818M
Other Receivables	33.53M	27.66M	26.94M	21.44M	26.72M
Total Receivables	614M	758M	810M	869M	844M
Inventory	1.08B	1.3B	1.15B	1.06B	1.12B
Prepaid Expenses	136M	162M	118M	137M	184M
Other Current Assets, Total	53.63M	88.62M	50.83M	296M	62.39M
Total Current Assets	3.93B	4.19B	4.23B	3.98B	4.3B
Gross Property Plant And Equipment	4.97B	4.91B	5.03B	4.97B	5.1B
Accumulated Depreciation	-791M	-893M	-1.04B	-1.12B	-1.24B
Net Property Plant And Equipment	4.18B	4.02B	3.99B	3.85B	3.86B
Long-term Investments	417M	534M	1.06B	2.3B	2.61B
Other Intangibles, Total	78.16M	43.01M	42.69M	43.76M	51.45M
Deferred Tax Assets Long-Term	632M	588M	677M	623M	606M
Other Long-Term Assets, Total	171M	1.06B	814M	780M	788M
Total Assets	9.4B	10.43B	10.81B	11.57B	12.21B
Liabilities
Accounts Payable, Total	160M	552M	348M	176M	156M
Accrued Expenses, Total	450M	353M	280M	297M	361M
Short-term Borrowings	2.05B	2.19B	2.32B	2.11B	1.72B
Current Portion of Long-Term Debt	247M	350M	272M	380M	283M
Current Portion of Leases	25.78M	44.06M	41.95M	38.79M	26.09M
Current Income Taxes Payable	55.52M	16.02M	138M	20.21M	129M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	244M	286M	307M	284M	241M
Total Current Liabilities	3.23B	3.79B	3.71B	3.31B	2.91B
Long-Term Debt	1.68B	1.99B	1.79B	1.34B	925M
Long-Term Leases	218M	448M	413M	354M	308M
Pension & Other Post Retirement Benefits	66.99M	59.82M	58.68M	47M	45.46M
Deferred Tax Liability Non Current	728M	671M	652M	670M	640M
Other Non Current Liabilities	24.64M	23.3M	23.44M	22.9M	21.27M
Total Liabilities	5.95B	6.99B	6.65B	5.75B	4.85B
Common Stock, Total	867M	867M	867M	867M	867M
Additional Paid In Capital	263M	271M	271M	271M	518M
Retained Earnings	2.12B	1.74B	1.75B	2.05B	3.67B
Comprehensive Income and Other	-307M	51.9M	624M	1.98B	1.24B
Total Common Equity	2.94B	2.93B	3.51B	5.16B	6.29B
Minority Interest	511M	515M	648M	660M	1.07B
Total Equity	3.45B	3.44B	4.16B	5.82B	7.35B
Total Liabilities And Equity	9.4B	10.43B	10.81B	11.57B	12.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.75M	86.75M	86.75M	86.75M	86.75M
ECS Total Common Shares Outstanding	86.75M	86.75M	86.75M	86.75M	86.75M
Book Value / Share	33.91	33.76	40.51	59.53	72.48
Tangible Book Value	2.86B	2.89B	3.47B	5.12B	6.24B
Tangible Book Value Per Share	33.01	33.27	40.02	59.03	71.89
Total Debt	4.22B	5.02B	4.84B	4.23B	3.26B
Net Debt	2.18B	3.15B	2.74B	2.62B	1.17B
Debt Equivalent of Unfunded Proj. Benefit Obligation	66.99M	59.82M	58.68M	47M	-
Debt Equivalent Oper. Leases	157M	211M	141M	171M	204M
Minority Interest, Total (Incl. Fin. Div)	511M	515M	648M	660M	1.07B
Equity Method Investments, Total	171M	155M	132M	155M	286M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	97.85M	104M	116M	139M	158M
Inventories - Work In Process, Total	6.24M	21.39M	22.63M	42.78M	30.07M
Inventories - Finished Goods, Total	923M	1.14B	957M	851M	898M
Inventories - Others	54.63M	34.42M	50.76M	32.09M	35.24M
Land - (BS)	1.46B	1.17B	1.17B	1.16B	1.15B
Buildings, Total	2.19B	2.24B	2.35B	2.3B	2.31B
Machinery, Total	965M	993M	1.07B	1.08B	1.12B
Assets on Operating Lease - Gross	57.2M	56.89M	58.09M	58.09M	58.09M
Assets on Operating Lease - Accumulated Depreciation	-14.29M	-15.85M	-18.11M	-19.84M	-20.88M
Accumulated Allowance for Doubtful Accounts (Supple)	3.3M	2.91M	4.44M	24.48M	36.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	120M	-311M	144M	-284M	-567M
Depreciation & Amortization - CF	168M	212M	212M	203M	195M
Amortization of Goodwill and Intangible Assets - (CF)	22.67M	6.55M	4.11M	3.18M	3.14M
Depreciation & Amortization, Total	191M	219M	216M	207M	198M
(Gain) Loss From Sale Of Asset	-182M	-72.35M	-234M	4.83M	-1.41M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-6.15M	-
Asset Writedown & Restructuring Costs	10M	35.3M	-	-	8.65M
(Income) Loss On Equity Investments - (CF)	19.14M	30.14M	18.26M	27.29M	61.01M
Stock-Based Compensation (CF)	-	-	-	-	640K
Provision and Write-off of Bad Debts	-2.46M	-396K	1.53M	20.04M	11.72M
Other Operating Activities, Total	-22.62M	86.01M	133M	162M	211M
Change In Accounts Receivable	-60.86M	-113M	-14.93M	-130M	-3.36M
Change In Inventories	210M	-391M	129M	-67K	-128M
Change In Accounts Payable	-159M	393M	-202M	-173M	-27.07M
Change in Other Net Operating Assets	-46.25M	-94.12M	-69.44M	52.48M	-55.81M
Cash from Operations	77.65M	-219M	121M	-121M	-292M
Capital Expenditure	-1.56B	-639M	-99.4M	-99.06M	-174M
Sale of Property, Plant, and Equipment	216M	102M	424M	2.9M	4.03M
Cash Acquisitions	-	-	-	-	-5.57M
Divestitures	-	-	-	-	-
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Sale (Purchase) of Intangible assets	-5.05M	-1.93M	-1.3M	-1.14M	-14.97M
Investment in Marketable and Equity Securities, Total	-137M	-84.86M	-251M	551M	1.5B
Other Investing Activities, Total	-6.95M	12.48M	-10.51M	11.04M	-14.42M
Cash from Investing	-1.5B	-612M	62.11M	465M	1.29B
Short Term Debt Issued, Total	826M	141M	133M	-	-
Long-Term Debt Issued, Total	1.25B	702M	154M	354M	574M
Total Debt Issued	2.08B	843M	287M	354M	574M
Short Term Debt Repaid, Total	-	-	-	-212M	-394M
Long-Term Debt Repaid, Total	-275M	-323M	-481M	-737M	-1.13B
Total Debt Repaid	-275M	-323M	-481M	-949M	-1.52B
Common Dividends Paid	-130M	-73.74M	-	-86.75M	-86.75M
Common & Preferred Stock Dividends Paid	-130M	-73.74M	-	-86.75M	-86.75M
Other Financing Activities, Total	-311M	-17.78M	-15.44M	-79.74M	553M
Cash from Financing	1.36B	428M	-210M	-761M	-483M
Foreign Exchange Rate Adjustments	-104M	244M	-38.28M	116M	-4.61M
Net Change in Cash	-162M	-158M	-64.9M	-301M	515M
Supplemental Items
Cash Interest Paid	37.17M	66.9M	105M	110M	74.12M
Cash Income Tax Paid (Refund)	60.83M	21.75M	21.75M	151M	27.52M
Levered Free Cash Flow	-1.46B	-689M	147M	-296M	33.5M
Unlevered Free Cash Flow	-1.43B	-645M	214M	-229M	79.79M
Change In Net Working Capital	-4.65M	130M	-53.96M	331M	-264M
Net Debt Issued / Repaid	1.8B	520M	-194M	-594M	-949M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-0.7	-0.94	0.42	-0.04	-1.63
Return on Total Capital	-0.88	-1.16	0.51	-0.04	-1.88
Return On Equity %	2.02	-8.57	4.45	-4.63	-7.29
Return on Common Equity	3.91	-10.59	4.47	-6.54	-9.91
Margin Analysis
Gross Profit Margin %	45.12	42.96	46.76	47.05	48.69
SG&A Margin	40.23	40.64	40.69	41.23	43.04
EBITDA Margin %	1.21	0.6	5.13	3.49	-3.37
EBITA Margin %	-1.58	-3.02	1.63	-0.08	-6.69
EBIT Margin %	-2.06	-3.16	1.54	-0.15	-6.76
Income From Continuing Operations Margin %	1.56	-6.24	3.69	-5.26	-10.45
Net Income Margin %	2.52	-6.57	3.13	-6.47	-12.35
Net Avail. For Common Margin %	2.52	-6.57	3.13	-6.47	-12.35
Normalized Net Income Margin	-0.22	-5.15	-0.26	-3.1	-5.52
Levered Free Cash Flow Margin	-30.57	-14.56	3.21	-6.74	0.73
Unlevered Free Cash Flow Margin	-30.07	-13.65	4.65	-5.22	1.74
Asset Turnover
Asset Turnover	0.54	0.48	0.43	0.39	0.39
Fixed Assets Turnover	1.35	1.15	1.15	1.12	1.19
Receivables Turnover (Average Receivables)	8.64	7.22	6.07	5.39	5.52
Inventory Turnover (Average Inventory)	2.15	2.26	1.99	2.1	2.16
Short Term Liquidity
Current Ratio	1.21	1.1	1.14	1.2	1.47
Quick Ratio	0.82	0.69	0.78	0.75	1.01
Operating Cash Flow to Current Liabilities	0.02	-0.06	0.03	-0.04	-0.1
Days Sales Outstanding (Average Receivables)	42.27	50.56	60.15	67.94	66.12
Days Outstanding Inventory (Average Inventory)	169.62	161.39	182.96	174.03	169.21
Average Days Payable Outstanding	37.19	44.49	71.84	42.77	25.07
Cash Conversion Cycle (Average Days)	174.7	167.46	171.27	199.2	210.26
Long Term Solvency
Total Debt/Equity	122.25	145.9	116.31	72.61	44.33
Total Debt / Total Capital	55.01	59.33	53.77	42.06	30.72
LT Debt/Equity	54.98	70.82	52.92	29.15	16.76
Long-Term Debt / Total Capital	24.74	28.8	24.47	16.89	11.61
Total Liabilities / Total Assets	63.28	66.98	61.5	49.66	39.76
EBIT / Interest Expense	-2.58	-2.15	0.67	-0.06	-4.19
EBITDA / Interest Expense	2.44	0.99	2.7	1.86	-1.52
(EBITDA - Capex) / Interest Expense	-38.64	-8.2	1.77	0.94	-3.87
Total Debt / EBITDA	45.42	72.72	16.88	21.15	-28.92
Net Debt / EBITDA	23.47	45.63	9.55	13.1	-10.42
Total Debt / (EBITDA - Capex)	-2.87	-8.81	25.82	41.92	-11.38
Net Debt / (EBITDA - Capex)	-1.48	-5.53	14.61	25.96	-4.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.45	-0.77	-2.93	-4.37	4.64
Gross Profit, 1 Yr. Growth %	-11.2	-5.51	5.66	-3.77	8.28
EBITDA, 1 Yr. Growth %	-79.21	-52.57	3.25K	-34.91	-201.06
EBITA, 1 Yr. Growth %	-154.17	95.83	-152.26	-104.73	8.6K
EBIT, 1 Yr. Growth %	-183.63	56.28	-147.22	-109.51	4.52K
Earnings From Cont. Operations, 1 Yr. Growth %	-30.49	-497.56	-157.31	-236.57	107.7
Net Income, 1 Yr. Growth %	-39.7	-358.63	-146.31	-297.25	99.83
Normalized Net Income, 1 Yr. Growth %	-104.23	2.63K	-95.14	1.05K	86.5
Diluted EPS Before Extra, 1 Yr. Growth %	-39.74	-359.63	-146.31	-297.25	99.83
Accounts Receivable, 1 Yr. Growth %	10.68	25.94	7.19	8.2	-3.48
Inventory, 1 Yr. Growth %	-19.85	20.56	-12.09	-7.15	5.35
Net Property, Plant and Equip., 1 Yr. Growth %	44.46	-3.87	-0.81	-3.39	0.16
Total Assets, 1 Yr. Growth %	15.24	10.92	3.66	7.02	5.51
Tangible Book Value, 1 Yr. Growth %	-7.75	0.78	20.3	47.48	21.79
Common Equity, 1 Yr. Growth %	-8.32	-0.43	19.99	46.94	21.75
Cash From Operations, 1 Yr. Growth %	-87.24	-381.72	-155.31	-287.27	141.28
Capital Expenditures, 1 Yr. Growth %	571.36	-59.1	-84.45	-0.35	75.32
Levered Free Cash Flow, 1 Yr. Growth %	-600.86	-52.67	-120.66	401.1	-111.31
Unlevered Free Cash Flow, 1 Yr. Growth %	-562.64	-54.92	-131.9	-3.28K	-134.82
Dividend Per Share, 1 Yr. Growth %	-43.33	-	-	0	300
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.55	-6.26	-1.85	-3.65	0.03
Gross Profit, 2 Yr. CAGR %	-12.59	-8.4	-0.08	0.83	2.08
EBITDA, 2 Yr. CAGR %	-65.42	-67.94	97.68	366.95	-18.89
EBITA, 2 Yr. CAGR %	-54.05	1.3	1.16	-84.28	102.83
EBIT, 2 Yr. CAGR %	-45.99	12.88	-14.09	-78.81	109.71
Earnings From Cont. Operations, 2 Yr. CAGR %	-26.3	66.24	50.95	-11.53	68.42
Net Income, 2 Yr. CAGR %	-30.34	24.88	9.44	-4.42	98.54
Normalized Net Income, 2 Yr. CAGR %	-82.39	-0.8	15.09	-25.32	362.59
Diluted EPS Before Extra, 2 Yr. CAGR %	-30.29	25.08	9.66	-4.42	98.54
Accounts Receivable, 2 Yr. CAGR %	-9.17	18.06	16.19	7.69	2.19
Inventory, 2 Yr. CAGR %	-14.45	-1.7	2.95	-9.65	-1.1
Net Property, Plant and Equip., 2 Yr. CAGR %	21.6	17.84	-2.35	-2.11	-1.63
Total Assets, 2 Yr. CAGR %	9.29	13.06	7.23	5.32	6.26
Tangible Book Value, 2 Yr. CAGR %	-3.43	-3.58	10.11	33.2	34.02
Common Equity, 2 Yr. CAGR %	-4.04	-4.46	9.3	32.78	33.75
Cash From Operations, 2 Yr. CAGR %	-41.56	-40.04	24.82	-25.59	112.57
Capital Expenditures, 2 Yr. CAGR %	253.62	65.7	-74.78	-60.63	32.18
Levered Free Cash Flow, 2 Yr. CAGR %	882.02	53.89	-68.18	-35.56	-24.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	5.45K	44.34	-61.37	-41.51	232.66
Dividend Per Share, 2 Yr. CAGR %	-31.28	-	8.47	-	100
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.71	-8.09	-5.16	-2.7	-0.96
Gross Profit, 3 Yr. CAGR %	-5.89	-10.29	-3.94	-1.33	3.25
EBITDA, 3 Yr. CAGR %	-49.87	-61.05	-5.38	36.51	180.35
EBITA, 3 Yr. CAGR %	-40.44	-26.32	-18.75	-63.56	29.07
EBIT, 3 Yr. CAGR %	-34.87	-23.68	-15.58	-58.75	27.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-20.44	29.26	16.57	46	17.58
Net Income, 3 Yr. CAGR %	-21.32	7.86	-10.28	33.19	22.22
Normalized Net Income, 3 Yr. CAGR %	-68.33	-10.34	-63.7	147.71	1.32
Diluted EPS Before Extra, 3 Yr. CAGR %	-21.29	8.05	-10.18	33.36	22.22
Accounts Receivable, 3 Yr. CAGR %	-8.74	1.28	14.32	13.46	3.83
Inventory, 3 Yr. CAGR %	-0.68	-4.09	-5.29	-0.53	-4.91
Net Property, Plant and Equip., 3 Yr. CAGR %	19.59	12.44	11.26	-2.7	-1.36
Total Assets, 3 Yr. CAGR %	9.11	9.83	9.84	7.16	5.39
Tangible Book Value, 3 Yr. CAGR %	-3.6	-2.05	3.8	21.38	29.28
Common Equity, 3 Yr. CAGR %	-3.59	-2.85	3.08	20.63	29
Cash From Operations, 3 Yr. CAGR %	-30.5	-1.28	-41.64	15.97	10.13
Capital Expenditures, 3 Yr. CAGR %	97.91	72.29	-24.7	-60.13	-35.23
Levered Free Cash Flow, 3 Yr. CAGR %	446.68	257.26	-20.29	-41.18	-63.92
Unlevered Free Cash Flow, 3 Yr. CAGR %	914.68	1.02K	-11.65	-45.71	-50.8
Dividend Per Share, 3 Yr. CAGR %	-22.13	-	-12.64	5.57	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.84	-1.97	-3.58	-6.34	-3.12
Gross Profit, 5 Yr. CAGR %	-2.28	-3.81	-3.61	-6	-1.57
EBITDA, 5 Yr. CAGR %	-37	-44.24	-12.49	-20.53	-11.04
EBITA, 5 Yr. CAGR %	-30.8	-20.05	-26.87	-60.29	17.15
EBIT, 5 Yr. CAGR %	-27	-19.25	-27.61	-54.29	21.49
Earnings From Cont. Operations, 5 Yr. CAGR %	-27.99	-2.7	2.79	11.07	35.05
Net Income, 5 Yr. CAGR %	-23.86	-7.49	-10.22	2.77	23.27
Normalized Net Income, 5 Yr. CAGR %	-51.1	-11.38	-48.59	-16.66	0.47
Diluted EPS Before Extra, 5 Yr. CAGR %	-23.82	-7.43	-10.13	2.88	23.36
Accounts Receivable, 5 Yr. CAGR %	-4.29	1.09	0.52	3.8	9.3
Inventory, 5 Yr. CAGR %	0.6	2.67	0.76	-6.35	-3.64
Net Property, Plant and Equip., 5 Yr. CAGR %	16.59	10.93	10.28	6.38	5.92
Total Assets, 5 Yr. CAGR %	7.71	9.41	8.35	8	8.39
Tangible Book Value, 5 Yr. CAGR %	-1.31	-1.95	1.67	10.77	14.97
Common Equity, 5 Yr. CAGR %	-1.33	-2.17	1.37	10.08	14.4
Cash From Operations, 5 Yr. CAGR %	-6.94	-18.3	-12.16	-11.84	-13.65
Capital Expenditures, 5 Yr. CAGR %	35.48	11.69	-13.19	-4.54	-5.69
Levered Free Cash Flow, 5 Yr. CAGR %	43.14	56.27	75.23	81.32	-35.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.92	50.08	174.46	245.58	-23.76
Dividend Per Share, 5 Yr. CAGR %	-13.93	-	-11.09	-11.09	21.67